{"id":35186,"date":"2025-06-13T15:36:48","date_gmt":"2025-06-13T07:36:48","guid":{"rendered":"https:\/\/flcube.com\/?p=35186"},"modified":"2025-06-13T15:36:49","modified_gmt":"2025-06-13T07:36:49","slug":"nvidia-and-novo-nordisk-collaborate-to-accelerate-ai-driven-drug-discovery","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=35186","title":{"rendered":"NVIDIA and Novo Nordisk Collaborate to Accelerate AI-Driven Drug Discovery"},"content":{"rendered":"\n

US chip manufacturer NVIDIA (NASDAQ: NVDA<\/a>) announced a strategic collaboration with Danish pharmaceutical giant Novo Nordisk (NYSE: NVO<\/a>) to enhance drug discovery processes through cutting-edge artificial intelligence (AI) applications. This partnership aligns with Novo Nordisk’s agreement with the Danish Center for AI (DCAI) to utilize the Gefion supercomputer, marking a significant step in integrating advanced AI technologies into pharmaceutical research.<\/p>\n\n\n\n

Collaboration Details<\/strong>
The companies plan to develop customized AI models and agents for Novo Nordisk’s early-stage research and clinical development programs. This initiative will leverage NVIDIA’s advanced simulation and physics-informed AI technologies to streamline and accelerate the drug discovery process.<\/p>\n\n\n\n

Technological Integration<\/strong>
DCAI’s Gefion supercomputer, powered by NVIDIA DGX SuperPOD, will serve as the AI factory for Novo Nordisk. The supercomputer will run drug discovery and AI agent workloads, utilizing NVIDIA BioNeMo for generative AI-driven drug discovery, NVIDIA NIM and NVIDIA NeMo microservices for customized agent workflows, and NVIDIA Omniverse to create simulation environments for physics-AI applications.<\/p>\n\n\n\n

Research Focus<\/strong>
Novo Nordisk researchers will engage in multiple AI-driven projects, including the development of single-cell models to predict cellular responses to drug candidates and the design of models for constructing molecules with pharmaceutical properties. Additionally, the collaboration will focus on building biomedical large language models using Novo Nordisk’s extensive scientific literature database to uncover correlations between genes, proteins, and diseases.-Fineline Info & Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

US chip manufacturer NVIDIA (NASDAQ: NVDA) announced a strategic collaboration with Danish pharmaceutical giant Novo…<\/p>\n","protected":false},"author":1,"featured_media":35187,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[99,1670,148,1671,860],"class_list":["post-35186","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-ai","tag-nasdaq-nvda","tag-novo-nordisk","tag-nvidia","tag-nyse-nvo"],"yoast_head":"\nNVIDIA and Novo Nordisk Collaborate to Accelerate AI-Driven Drug Discovery - Insight, China's Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"US chip manufacturer NVIDIA (NASDAQ: NVDA) announced a strategic collaboration with Danish pharmaceutical giant Novo Nordisk (NYSE: NVO) to enhance drug discovery processes through cutting-edge artificial intelligence (AI) applications. This partnership aligns with Novo Nordisk's agreement with the Danish Center for AI (DCAI) to utilize the Gefion supercomputer, marking a significant step in integrating advanced AI technologies into pharmaceutical research.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=35186\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NVIDIA and Novo Nordisk Collaborate to Accelerate AI-Driven Drug Discovery\" \/>\n<meta property=\"og:description\" content=\"US chip manufacturer NVIDIA (NASDAQ: NVDA) announced a strategic collaboration with Danish pharmaceutical giant Novo Nordisk (NYSE: NVO) to enhance drug discovery processes through cutting-edge artificial intelligence (AI) applications. This partnership aligns with Novo Nordisk's agreement with the Danish Center for AI (DCAI) to utilize the Gefion supercomputer, marking a significant step in integrating advanced AI technologies into pharmaceutical research.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=35186\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China's Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-13T07:36:48+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-13T07:36:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/1306.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=35186#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=35186\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"NVIDIA and Novo Nordisk Collaborate to Accelerate AI-Driven Drug Discovery\",\"datePublished\":\"2025-06-13T07:36:48+00:00\",\"dateModified\":\"2025-06-13T07:36:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=35186\"},\"wordCount\":237,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=35186#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/1306.webp\",\"keywords\":[\"AI\",\"NASDAQ: NVDA\",\"Novo Nordisk\",\"NVIDIA\",\"NYSE: NVO\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=35186#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=35186\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=35186\",\"name\":\"NVIDIA and Novo Nordisk Collaborate to Accelerate AI-Driven Drug Discovery - Insight, China's Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=35186#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=35186#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/1306.webp\",\"datePublished\":\"2025-06-13T07:36:48+00:00\",\"dateModified\":\"2025-06-13T07:36:49+00:00\",\"description\":\"US chip manufacturer NVIDIA (NASDAQ: NVDA) announced a strategic collaboration with Danish pharmaceutical giant Novo Nordisk (NYSE: NVO) to enhance drug discovery processes through cutting-edge artificial intelligence (AI) applications. This partnership aligns with Novo Nordisk's agreement with the Danish Center for AI (DCAI) to utilize the Gefion supercomputer, marking a significant step in integrating advanced AI technologies into pharmaceutical research.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=35186#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=35186\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=35186#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/1306.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/1306.webp\",\"width\":1080,\"height\":608,\"caption\":\"NVIDIA and Novo Nordisk Collaborate to Accelerate AI-Driven Drug Discovery\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=35186#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NVIDIA and Novo Nordisk Collaborate to Accelerate AI-Driven Drug Discovery\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"NVIDIA and Novo Nordisk Collaborate to Accelerate AI-Driven Drug Discovery - Insight, China's Pharmaceutical Industry","description":"US chip manufacturer NVIDIA (NASDAQ: NVDA) announced a strategic collaboration with Danish pharmaceutical giant Novo Nordisk (NYSE: NVO) to enhance drug discovery processes through cutting-edge artificial intelligence (AI) applications. This partnership aligns with Novo Nordisk's agreement with the Danish Center for AI (DCAI) to utilize the Gefion supercomputer, marking a significant step in integrating advanced AI technologies into pharmaceutical research.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=35186","og_locale":"en_US","og_type":"article","og_title":"NVIDIA and Novo Nordisk Collaborate to Accelerate AI-Driven Drug Discovery","og_description":"US chip manufacturer NVIDIA (NASDAQ: NVDA) announced a strategic collaboration with Danish pharmaceutical giant Novo Nordisk (NYSE: NVO) to enhance drug discovery processes through cutting-edge artificial intelligence (AI) applications. This partnership aligns with Novo Nordisk's agreement with the Danish Center for AI (DCAI) to utilize the Gefion supercomputer, marking a significant step in integrating advanced AI technologies into pharmaceutical research.","og_url":"https:\/\/flcube.com\/?p=35186","og_site_name":"Insight, China's Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-06-13T07:36:48+00:00","article_modified_time":"2025-06-13T07:36:49+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/1306.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=35186#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=35186"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"NVIDIA and Novo Nordisk Collaborate to Accelerate AI-Driven Drug Discovery","datePublished":"2025-06-13T07:36:48+00:00","dateModified":"2025-06-13T07:36:49+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=35186"},"wordCount":237,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=35186#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/1306.webp","keywords":["AI","NASDAQ: NVDA","Novo Nordisk","NVIDIA","NYSE: NVO"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=35186#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=35186","url":"https:\/\/flcube.com\/?p=35186","name":"NVIDIA and Novo Nordisk Collaborate to Accelerate AI-Driven Drug Discovery - Insight, China's Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=35186#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=35186#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/1306.webp","datePublished":"2025-06-13T07:36:48+00:00","dateModified":"2025-06-13T07:36:49+00:00","description":"US chip manufacturer NVIDIA (NASDAQ: NVDA) announced a strategic collaboration with Danish pharmaceutical giant Novo Nordisk (NYSE: NVO) to enhance drug discovery processes through cutting-edge artificial intelligence (AI) applications. This partnership aligns with Novo Nordisk's agreement with the Danish Center for AI (DCAI) to utilize the Gefion supercomputer, marking a significant step in integrating advanced AI technologies into pharmaceutical research.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=35186#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=35186"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=35186#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/1306.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/1306.webp","width":1080,"height":608,"caption":"NVIDIA and Novo Nordisk Collaborate to Accelerate AI-Driven Drug Discovery"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=35186#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"NVIDIA and Novo Nordisk Collaborate to Accelerate AI-Driven Drug Discovery"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/06\/1306.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/35186","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=35186"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/35186\/revisions"}],"predecessor-version":[{"id":35188,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/35186\/revisions\/35188"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/35187"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=35186"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=35186"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=35186"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}